Mera Pharmaceuticals Company Top Insiders
| MRPI Stock | USD 0.0001 0.00 0.00% |
Mera Pharmaceuticals employs about 7 people. The company is managed by 6 executives with a total tenure of roughly 13 years, averaging almost 2.0 years of service per executive, having 1.17 employees per reported executive. Assessment of Mera Pharmaceuticals' management performance can provide insight into the firm performance.
| Joyce Markley Director Secretary, Director |
| Lawrence Wolfe Insider VP Officer |
Mera |
Mera Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (1.7448) % which means that it has lost $1.7448 on every $100 spent on assets. This is way below average. Mera Pharmaceuticals' management efficiency ratios could be used to measure how well Mera Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Mera Pharmaceuticals Workforce Comparison
Mera Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 420. Mera Pharmaceuticals claims roughly 7.0 in number of employees contributing just under 2% to equities under Health Care industry.
Mera Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Mera Pharmaceuticals Price Series Summation is a cross summation of Mera Pharmaceuticals price series and its benchmark/peer.
Mera Pharmaceuticals Notable Stakeholders
A Mera Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mera Pharmaceuticals often face trade-offs trying to please all of them. Mera Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mera Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Joyce Markley | Secretary, Director | Profile | |
| Lawrence Wolfe | VP Officer | Profile | |
| Rafi Markarians | Treasurer Director | Profile | |
| Benny Doro | Interim CEO | Profile | |
| Melanie Kelekolio | Gen VP | Profile | |
| Russell Yamamoto | Director Planning | Profile |
About Mera Pharmaceuticals Management Performance
The success or failure of an entity such as Mera Pharmaceuticals often depends on how effective the management is. Mera Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada. Mera Pharma is traded on OTC Exchange in the United States.
Mera Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Mera Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mera Pharmaceuticals within its industry.Mera Pharmaceuticals Manpower Efficiency
Return on Mera Pharmaceuticals Manpower
| Revenue Per Employee | 43.2K | |
| Revenue Per Executive | 50.4K | |
| Net Loss Per Employee | 797 | |
| Net Loss Per Executive | 930 |
Complementary Tools for Mera Pink Sheet analysis
When running Mera Pharmaceuticals' price analysis, check to measure Mera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mera Pharmaceuticals is operating at the current time. Most of Mera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Mera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Mera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |